Pharma & Biotech Arecor's ultra-concentrated insulin holds ultra-rapid profile in peer-reviewed study - UPDATE By Ian Lyall 13/08
Pharma & Biotech Citi sees Hikma discount as unwarranted after upgrade to forecasts By Ian Lyall 12/08
Pharma & Biotech CelLBxHealth's blood test spots hard-to-detect cells from brain tumours By Ian Lyall 12/08
Pharma & Biotech BSF Enterprise inks worldwide ETSYL commercialisation deal for luxury skincare By Ephrem Joseph 11/08
Pharma & Biotech CelLBxHealth's Parsortix technology shows potential in glioblastoma detection and monitoring By Ephrem Joseph 11/08
Pharma & Biotech Verici Dx gains Olink Certified Service Provider status to expand proteomics offering By Ephrem Joseph 11/08
Pharma & Biotech Rare disease specialist Santhera is delivering life-changing treatment for DMD By Proactive 10/08
Pharma & Biotech RBC cuts Oxford BioMedica target by a fifth but sticks with 'buy' call By Ian Lyall 10/08
Pharma & Biotech ValiRx set to land second European patent for Cytolytix cancer peptide By Ian Lyall 10/08
Pharma & Biotech ImmuPharma appoints Kymos as third Kapiglucagon partner in build towards clinic By Ian Lyall 10/08
Pharma & Biotech Oxford BioMedica tanks 24% after earnings alert; brokers take stock By Ian Lyall 07/08
Pharma & Biotech Oxford Biomedica cuts 2026 revenue guidance as clients delay orders By Ian Lyall 07/08
Pharma & Biotech Hikma jumps 10% as brokers point to profit beat and undemanding rating By Ian Lyall 06/08
Pharma & Biotech Wellnex Life more than doubles on A$21 million sale of Pain Away brand By Ian Lyall 06/08
Pharma & Biotech Brokers split on AstraZeneca merger talk as shares recover some ground By Ian Lyall 04/08
